Skip To Main Content
Yan-Ying Shen on Muck Rack

Yan-Ying Shen

As seen in: Color Research & Application, Diagnostic Pathology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yan-Ying

Contact Yan-Ying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Clinicopathologic characteristics, diagnostic clues, and prognoses of patients with multiple sporadic gastrointestinal stromal tumors: a case series and review of the literature

|
By Yan-Ying Shen, Xin-Li Ma, Lin-Xi Yang, Wen-Yi Zhao
| Diagnostic Pathology Verified
Yan-Ying Shen1,2 na1, Xin-Li Ma1 na1, Lin-Xi Yang1, Wen-Yi Zhao1, Lin Tu1, Chun Zhuang1, Bo Ni1, Qiang Liu2, Ming Wang1 & Hui Cao1 Diagnostic Pathology volume 15, Article number: 56 (2020) Cite this article Abstract Background Most sporadic gastrointestinal stromal tumors (GISTs) occur as solitary tumors, while multiple sporadic GISTs are extremely rare and often misdiagnosed as metastatic GISTs, leading to inappropriate treatment.
Open in Who Shared Issue with article?

FCN-A/2, acting as a new regulator of macrophage polarization, mediates the inflammatory response in experimental mouse colitis

|
By Yan Xie, Hong-Liang Li, Yi-Fei Yang, Yi-Dan Zhou, Jia-Chen Hu, Feng-Ling Luo, Yan-Ying Shen, Wen-Xiu Bian, Zhi-Nan Yin, Xiao-Lian Zhang
| Color Research & Application Verified
Human ficolin-2 (FCN-2) and mouse ficolin-A (FCN-A, a ficolin-2-like molecule in mouse) are activators of the lectin complement pathway, present in normal plasma and usually associated with infectious diseases, but little is known about the role of FCN-A/2 in inflammatory bowel disease (IBD). In our present study, we found that IBD patients exhibited much higher serum FCN-2 levels than healthy controls.
Open in Who Shared Issue with article?
See all 2 articles